Targeted alpha therapy: progress in radionuclide production, radiochemistry, and applications.

Nelson, Bryce J. B., Andersson, Jan D., Wuest, Frank·2020·Pharmaceutics
DOI 10.3390/pharmaceutics13010049

Cited by (193)

Items 101–193 of 193

  1. Enhancing the Therapeutic Effect of 2-211At-astato-α-methyl-L-phenylalanine with Probenecid Loading
    Hirofumi Hanaoka, Yasuhiro Ohshima, Hiroyuki Y. Suzuki, Ichiro Sasaki, Tadashi Watabe, Kazuhiro Ooe, Shigeki Watanabe, Noriko S. Ishioka · 2021 · Cancers
  2. Radiological and Molecular Analysis of Radioiodinated Anastrozole and Epirubicin as Innovative Radiopharmaceuticals Targeting Methylenetetrahydrofolate Dehydrogenase 2 in Solid Tumors
    Mazen Abdulrahman Binmujlli · 2024 · Pharmaceutics
  3. Development of a 213Bi-Labeled Pyridyl Benzofuran for Targeted α-Therapy of Amyloid-β Aggregates
    Aidan A Bender, Emily K Kirkeby, D. Cross, Satoshi Minoshima, Andrew G Roberts, Tara Mastren · 2024 · Journal of Nuclear Medicine
  4. A Novel Single-Step-Labeled 212Pb-CaCO3 Microparticle for Internal Alpha Therapy: Preparation, Stability, and Preclinical Data from Mice
    Ruth Gong Li, Kim Lindland, Tina Bjørnlund Bønsdorff, Sara Westrøm, Roy H. Larsen · 2021 · Materials
  5. Feasibility of producing 225Ac via thermal neutron irradiation of 226Ra: A systematic theoretical study
    Long Qiu, Jinsong Zhang, Tu Lan, Jiali Liao, Yuanyou Yang, Feize Li, Ning Liu · 2024 · Nuclear Analysis
  6. Peptide receptor radionuclide therapy: a new era of radiation nephropathy
    Abhirami Das, Ayse Tuba Kendi, Sandhya Manohar · 2025 · Nephrology Dialysis Transplantation
  7. Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope
    Aditya Luhung, Aliya Nur Hasanah, Danni Ramdhani · 2026 · Drug Design Development and Therapy
  8. In vivo-stable bis-iminobiotin for targeted radionuclide delivery with the mutant streptavidin
    Toshifumi Tatsumi, Songji Zhao, Akitomo Kasahara, Miho Aoki, Ken‐ichi Nishijima, Naoyuki Ukon, Tatsuhiko Kodama, Kazuhiro Takahashi, Akira Sugiyama, Kohshin Washiyama et al. · 2024 · Bioorganic & Medicinal Chemistry Letters
  9. Production of radionuclides: Cyclotrons and reactors
    Martina Benešová, Gerald Reischl · 2021 · Elsevier eBooks
  10. Monte Carlo simulation study to explore optimum conditions for Astatine-211 SPECT
    Akihiko Takahashi, Ryosuke Kajiya, Shingo Baba, Masayuki Sasaki · 2023 · Radiological Physics and Technology
  11. The effects of nuclear level density model and alpha optical model potential to the excitation functions of novel therapeutic radionuclides
    N. Kamal, Sana N. Nizam, A. Abdul Aziz · 2023 · Applied Radiation and Isotopes
  12. In vitro and in vivo study of 221Fr and 213Bi progeny release from the 225Ac-labelled TiO2 nanoparticles
    Michal Sakmár, Ján Kozempel, Jan Kučka, Tereza Janská, Matěj Štíbr, Lukáš Ondrák, Kateřina Ondrák Fialová, Martin Vlk, Luděk Šefc, Frank Bruchertseifer et al. · 2024 · Nuclear Medicine and Biology
  13. Gravimetric Drop-on-Demand Inkjet Deposition for Imaging Phantoms with Traceable Activity
    Sean Jollota, Denis E. Bergeron, R. Michael Verkouteren, Svetlana Nour, Ryan Fitzgerald, Ohyun Kwon, Jeffrey L. Radtke, Bryan P. Bednarz, Brian W. Miller, Larry A. DeWerd · 2024 · Applied Radiation and Isotopes
  14. Breaking the Silence of Tumor Response: Future Prospects of Targeted Radionuclide Therapy
    Chandan Kumar, Aanchal Udaynath Pareri, Arunkumar Singh Koijam · 2021 · Anti-Cancer Agents in Medicinal Chemistry
  15. Exploiting Radiation Induction of Antigens in Cancer: Targeted Drug Delivery
    Vaishali Kapoor, Abhay Kumar Singh, Calvin D. Lewis, Sapna Deore, Dennis E. Hallahan · 2022 · International Journal of Molecular Sciences
  16. Pr(H3BNMe2BH3)3 and Pr(thd)3 as Volatile Carriers for Actinium-225. Deposition of Actinium-Doped Praseodymium Boride Thin Films for Potential Use in Brachytherapy
    Scott R. Daly, Brian J. Bellott, Daniel R. McAlister, E. Philip Horwitz, Gregory S. Girolami · 2022 · Inorganic Chemistry
  17. An optimization study for targeted alpha therapy: Ion behaviours and dose calculations within ICRU-compact bone tissue
    Ayhan Kara · 2022 · Applied Radiation and Isotopes
  18. Production and radiochemistry of the in vivo PET generator 140Nd/140Pr as an imaging surrogate for F-block therapeutic radionuclides
    Mangi lal Godara, Shelbie Jaylene Cingoranelli, Volkan Tekin, Shefali Saini, Sharon L. Samuel, Hailey A. Houson, Suzanne E. Lapi · 2025 · Scientific Reports
  19. Emerging role of radiopharmaceutical therapy in oncology: advances, challenges, and future directions
    Laura Ordas, Sean Foster, Phuc Pham, Andy S. Ollendorff, Varun Gnanasekar, Mahmoud Toulany, Quaovi H. Sodji · 2026 · JNCI Cancer Spectrum
  20. Design and development of the DE-SPECT system: a clinical SPECT system for broadband multi-isotope imaging of peripheral vascular disease
    Elena Maria Zannoni, P Sankar, Yihong Jin, Cheng Liu, Albert J. Sinusas, Scott D. Metzler, Ling-Jian Meng · 2024 · Physics in Medicine and Biology
  21. Environmental geochemistry of radionuclides (Environmental radiochemistry)
    Yoshio Takahashi, A. Yamaguchi, Takumi Yomogida · 2024 · Treatise on Geochemistry
  22. Nanoradiopharmaceuticals: An Attractive Concept in Oncotherapy
    Ruitong Hou, Ning Liu, Feize Li · 2024 · ChemMedChem
  23. Recent advances in spatio-temporally controllable systems for management of glioma
    Huiwen Zhang, Wanqi Zhu, Wei Pan, Xiuyan Wan, Na Li, Bo Tang · 2024 · Asian Journal of Pharmaceutical Sciences
  24. Triacetate of Benzoazacrown Compound as a Chelator for Lead Cations Promising for Targeted Radiopharmaceuticals
    Bayirta Vladimirovna Egorova, Lyubov Sergeevna Zamurueva, Anastasia D. Zubenko, Пашанова Анна Вячеславовна, Zeena Subramonia Pillai, Olga Anatol'evna Fedorova, Stepan Nikolaevich Kalmykov · 2021 · Macroheterocycles
  25. Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy
    Yuki Iizuka, Yoshiyuki Manabe, Kazuhiro Ooe, Atsushi Toyoshima, Xiaojie Yin, Hiromitsu Haba, Kazuya Kabayama, Koichi Fukase · 2023 · International Journal of Molecular Sciences
  26. α Emitter-Labeled Radiopeptides for Targeted α Therapy of Tumors
    Patrick Arthur Cieslik, Björn Wängler, Carmen Wängler · 2025 · Journal of Medicinal Chemistry
  27. Radiopharmaceutical therapy: From bench to bedside
    Qing Liang, Xiaoyan Li, Hancheng Cai, Wenyu Song, Xiaoli Lan, Michael C. Veronesi, Weibo Cai · 2025 · Acta Pharmaceutica Sinica B
  28. Combination therapy of an 211At-labeled RGD peptide and immune checkpoint blockade to enhance antitumor efficacy
    Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Takashi Nakamura, Atsushi Furukawa, Zhuoqing Chen, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Takahashi et al. · 2025 · European Journal of Nuclear Medicine and Molecular Imaging
  29. The use of radiopharmaceuticals in targeted cancer therapy: a narrative review
    Amirreza Khalaji · 2025 · International Journal of Physiology Pathophysiology and Pharmacology
  30. Radiopharmaceuticals for Therapy
    Shankar Vallabhajosula · 2023 · Springer eBooks
  31. Chelator Design and Radiolabeling Chemistry of Radiometals
    Viktoria E. Krol, Mukesh K. Pandey · 2025 · Royal Society of Chemistry eBooks
  32. Displacement complexing chromatography with DTPA-based eluents under irradiation conditions
    Oleg V. Kharitonov, L. A. Firsova, Evgeny Anatolievich Kozlitin · 2025 · Journal of Radioanalytical and Nuclear Chemistry
  33. Development of 223Ra-labeled polymeric nanocarriers with variable administration routes for alpha-therapy of colorectal cancer
    Alisa S. Postovalova, Vladislava A. Rusakova, Darya R. Akhmetova, Yulia A. Tishchenko, Dmitry S. Sysoev, Michail A. Nadporojskii, Konstantin S. Sivak, Sergei Alexandrovich Shipilovskikh, Alexander S. Timin · 2025 · Drug Delivery and Translational Research
  34. Ab initio multiconfigurational calculations of experimentally significant energy levels and transition rates in Lr i ( Z = 103 )
    Joseph S. Andrews, A. I. Bondarev, Per Jönsson, Jon Grumer, S. Raeder, S. Fritzsche, Jacek Bieroń · 2025 · Physical Review A
  35. Alpha Therapy Beyond TOC and TATE—Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3
    Lukas Greifenstein, Marcel Martin, Sarah Stephan, Aleksandr Eismant, Carsten Sven Kramer, Christian Landvogt, Corinna Mueller, Frank Rösch, Richard Paul Baum · 2026 · Pharmaceuticals
  36. Delta-like Ligand 3Directed 225 Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models
    Tran Hoang, David Bauer, Aidan Ingham, Ileana C. Miranda, Lukas M. Carter, Alexa L. Michel, Roberto De Gregorio, Juliana Welk, Hong Zhong, John Thomas Poirier et al. · 2026 · Journal of Nuclear Medicine
  37. Medicinal (Radio) Chemistry: Building Radiopharmaceuticals for the Future
    Martha Sahylí Ortega Pijeira, Paulo Sérgio Gonçalves Nunes, Samila Leon Chaviano, Aida Mary Abreu Diaz, Jean N. DaSilva, Eduardo Ricci‐Júnior, Luciana Magalhães Rebêlo Alencar, Xiaoyuan Shawn Chen, Ralph Santos‐Oliveira · 2023 · Current Medicinal Chemistry
  38. Targeted Alpha Therapy in Cancer Management: Therapeutic Prospects of Nuclear Medicine in Oncology
    Sipho Mdanda, Amanda Henrietta Mdlophane, Honest Ndlovu, Keamogetswe Ramonaheng, Milani Qebetu, Johncy Mahapane, Mankgopo Kgatle, Yonwaba V. Mzizi, Reabetswe Sebatana, Zamani E. D. Cele et al. · 2023 · Interdisciplinary cancer research
  39. Semi-Permanent Mass Production of Ac-225 for Cancer Therapy by the (3n,x) Reaction in Pressurized Water Reactor
    Daiki Iwahashi, Yuto Sasaki, Tomoatsu Shinohara, Naoyuki Takaki · 2023 · Processes
  40. Qualitative and quantitative imaging of alpha‐emitting radiopharmaceuticals
    Lan Wang, Jingjing Lou, Xuecen Cao, Lina Jia, Shuai Xue, Xingdang Liu, Lan Zhang, Xiao Li · 2024 · iRadiology
  41. Simulation of cell cycle effects on DNA strand break induction due to α -particles
    Laura Ballisat, Chiara De Sio, L. Beck, Anna L. Chambers, Mark Simon Dillingham, Susanna Guatelli, D. Sakata, Yuyao Shi, Jinyan Duan, Jaap J. Velthuis et al. · 2024 · Physica Medica
  42. State of the art and future perspectives of new radionuclides in Nuclear Medicine. Part II
    L. Sancho, A. Roteta, I. Torres, M. de Arcocha, Rocío Ramos-Membrive, M.L. Domínguez, Juan José Rosales, Elena Prieto, Gemma Quincoces · 2025 · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
  43. Preirradiation of Spheroids with 225Ac-Trastuzumab Improves Penetration of 225Ac-Liposomes and MIRDcell Predictions of Responses to Drug Cocktails
    Hima Tallam, Rajiv Nair, Aira Sarkar, Sumudu Katugampola, Stavroula Sofou, Roger W. Howell · 2025 · Journal of Nuclear Medicine
  44. Delivery of radiopharmaceuticals and theranostic agents: targeted alpha therapy
    Sayandev Chatterjee, Kenneth R. Czerwinski, Hilary A. Fitzgerald, Andrew L. Lakes, Zuolei Liao, Russell C. Ludwig, Katie M. McBride, Vladislav P. Vlasenko · 2022 · Elsevier eBooks
  45. PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer
    В. К. Тищенко, Василий Михайлович Петриев, Оксана Петровна Власова, В. В. Крылов, П. В. Шегай, С. А. Иванов, А. Д. Каприн · 2022 · Physics of Atomic Nuclei
  46. Status of α-emitter Radioimmunoconjugates for Targeted Therapy
    Mobina Rabiei, Ahmad Reza Vaez Alaei, Hassan Yousefnia · 2023 · Current Radiopharmaceuticals
  47. Crown ether-based cloud point extraction for lead-212 enrichment from thorium series
    Shiquan Cao, Baijia Hao, Zhi Chen · 2024 · New Journal of Chemistry
  48. Voxel based 211At dosimetry using CT and SPECT data with equivalent source term optimization
    Jinyang Li, Xingchen Zhou, Hui Wang, Jun-Liang Du, Wenming Zhou · 2025 · Journal of Radioanalytical and Nuclear Chemistry
  49. Using radioactive waste for targeted alpha therapy: Advancing a sovereign Australian supply of 225Ac and 212Pb
    Grant Douglas, Darren J. Koppel, Tom Cresswell, Simon G. Puttick, John Phalen · 2025 · Journal of Environmental Radioactivity
  50. Separation of radium from natural thorium by precipitation and barium carbonate co-precipitation
    Lingyuan Liao, Rulong Ren, Jing Tang, Xuexiang He, Shunyan Ning, Yuezhou Wei, Lifeng Chen · 2025 · Journal of Radioanalytical and Nuclear Chemistry
  51. Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with 212Pb alpha-radioimmunotherapy targeting CD20
    Isabelle Quelven, Amal Saidi, Magali Sage, Erick Mora‐Ramirez, Julien J.-C. Torgue, Michel Cogné, Stéphanie Durand-Panteix · 2025 · EJNMMI Research
  52. Current Status of PSMA-Targeted Agents Based on Small Molecules for Prostate Cancer in Preclinical Studies
    Ayman Muzammal, Kyo Chul Lee, Sairan Eom · 2026 · Nuclear Medicine and Molecular Imaging
  53. 177Lu-PSMA for prostate cancer: progress, challenges and future perspectives
    Zhen Xi, Shiyu Ji, Yu Zhang, Ming-Hui Sun, Gaozhen Jia, Qi Jiang · 2026 · Asian Journal of Andrology
  54. The Present and Future of THERANOSTICS
    Winnie Wing-Chuen Lam, Sue Ping Thang, Kelvin Siu Hoong Loke, Pei Ing Ngam, Andrew Eik‐Hock Tan, Lenith Tai‐Jit Cheng, Sidney Yu, Anna Siah Lee Ler, Damian Li‐Kin Khor, Soma Somanesan et al. · 2026 · Asia-Pacific Journal of Clinical Oncology
  55. Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation
    Junzhi Liu, Xiaoyu Zuo, Xue Yang, Xinyue Wang, Lu Gan, Jianxin Xue · 2026 · Molecular Cancer
  56. Improved 140Nd Production for the 140Nd/140Pr In Vivo Generator through Target Recycling and Radiochemical Optimization
    Mangi lal Godara, Gabriel Dufour, Anna Buryachenko, Suzanne E. Lapi · 2026 · ACS Omega
  57. Biodistribution of 213Bi–Metallothionein and 213Bi–IgG in Intact Mice
    Василий Михайлович Петриев, В. К. Тищенко, П. В. Шегай, С. А. Иванов, А. Д. Каприн · 2022 · Physics of Atomic Nuclei
  58. Nanoparticle-Mediated Radiation Therapy
    Mudasir Ashraf Shah, Arfat Firdous, Ghulam Nabi Dar · 2024 · Springer eBooks
  59. Radiobiology of Targeted Alpha Therapy
    Michael K. Schultz, Jean‐Pierre Pouget, Frank R. Wuest, Bryce J. B. Nelson, Jan D. Andersson, Sarah M. Cheal, Mengshi Li, Fiorenza Ianzini, Sangeeta Ray, Stephen A. Graves et al. · 2022 · Elsevier eBooks
  60. Monte Carlo approach to comparison of parallel-hole collimators of clinical scintillation camera system for imaging astatine-211 (At-211)
    Kohei Nakanishi, Seiichi Yamamoto, J. Kataoka · 2022 · Journal of Instrumentation
  61. Chemistry of Therapeutic Radionuclides
    Shankar Vallabhajosula · 2023 · Springer eBooks
  62. Crown Ether-Based Cloud Point Extraction for Lead-212 Enrichment from Thorium Series
    Shiquan Cao, Baijia Hao, Zhi Chen · 2024 · SSRN Electronic Journal
  63. Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear: Parte II
    L. Sancho, A. Roteta, I. Torres, M. de Arcocha, Rocío Ramos-Membrive, M.L. Domínguez, Juan José Rosales, Elena Prieto, Gemma Quincoces · 2025 · Revista Española de Medicina Nuclear e Imagen Molecular
  64. Chemical coupling of biological magnetosomes with amine‐functionalized therapeutic antibody conjugates
    Sandy M. Payan, Lucía Gandarias, Romain Avellan, Damien Faivre, Sandra Prévéral · 2025 · Journal of Chemical Technology & Biotechnology
  65. MIR dosimetry using CR-39 based α spectroscopy
    M Sreena, E S Keerthi, Cherumukku Vallabhan Midhun, P V Arun, M. M. Musthafa · 2025 · Applied Radiation and Isotopes
  66. Physical behaviors and dose calculations of alpha-emitter radionuclides ( 227 Th, 213 Bi, and 211 At) and their daughter nuclei in targeted alpha therapy for breast tissue
    Abayomi M. Olaosun, Caleb Ayoade Aborisade, Denen E. Shian, Peter Taiwo Osuolale, Oluwaseun Olaitan Oloyede, Fatai Akintunde Balogun · 2025 · Radiation effects and defects in solids
  67. Roadmap of development of trackable anticancer agents based on metal complexes “Strategies and Perspectives for Precision Oncology and theranostics”
    Ewen Bodio, Julie Pineau · 2025 · Advances in inorganic chemistry
  68. Additional file 1 of In vivo stable 211At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure
    Suzuki, Hiroyuki, Kannaka, Kento, Mizuki Hirayama, Yamashita, Tomoki, Yuta Kaizuka, Kobayashi, Ryota, Yasuda, Takahiro, Takahashi, Kazuhiro, Uehara, Tomoya · 2024 · Figshare
  69. An Integrated Analysis of Four Targeted Thorium Conjugates to Assess the 227 Th and 223 Ra Distribution and Tissue-Related Radiation
    Michael Block, Adriaan Cleton, Carsten Zieschang, Sandra Johanssen, Thorsten Poethko, Hartwig Hennekes, Christoph Niederalt · 2025 · Cancer Biotherapy and Radiopharmaceuticals
  70. 68 Ga/ 211 At-Labeled Specific NPY1R Peptide-Based Molecular Probe for Glioma-Targeted Imaging and Alpha Therapy
    Rong Gan, Duling Xu, Weihao Liu, Jiadi Liu, Yi Yang, Ning Liu, Qiyue Zhang, Zhimin Wang, Hongyan Li · 2026 · Biomacromolecules
  71. Anti-cancer and dual inhibitory potential of PI3K/AKT and Ras/MAPK/ERK signalling of a novel zinc (II) trinuclear complex with tetradentate schiff base ligand and azido ion in prostate adenocarcinoma: synthesis, in silico and in vitro evaluation
    Abdul Wasai, Adhiraj Roy, Mamata Barua, Pameli Ghosh, Anjali Saxena, Yassir Boulaamane, Nainee Goyal, Anshuman Chandra, Subratanath Koner, Sandip Saha et al. · 2026 · Journal of Molecular Structure
  72. Hedefe Yönelik Alfa Tedavisi Fiziksel Prensiplerden Klinik Uygulamaya
    Fatih Beytur · 2026 · Akademisyen Kitabevi eBooks
  73. Performance Evaluation of Single- and Double-Layer CZT Compton Cameras for 225 Ac Imaging
    Gyohyeok Song, Biswajit Das, Youngho Seo, Gyuseong Cho, J. Caravaca Rodríguez · 2026 · IEEE Transactions on Nuclear Science
  74. [225Ac]Ac–anti-DLL3 targeted alpha therapy for neuroendocrine tumors: preclinical radiosynthesis, biodistribution, and therapeutic efficacy
    Syed Qaiser Shah, Ralph Santos‐Oliveira, Derya İlem‐Özdemir · 2026 · Journal of Radioanalytical and Nuclear Chemistry
  75. Highly Efficient Extraction of 212 Pb/ 212 Bi from the Decay Chain of 232 Th‐Based on Anion Exchange in Bromide Medium
    Lifeng Chen, Wannian Feng, Yuezhou Wei, Xuexiang He, Shaoying Wang, Zhongyuan Zhou, Qian Wu, Ningchao Zheng, Xiangbiao Yin, X. H. Li et al. · 2026 · Advanced Science
  76. Efficient extraction of radium by DtBuCH18C6: performance and coordination study
    B. S. Li, Chengyun Fu, Yufang Yan, Mark Julian Henderson, Xinyue Chen, Shan Zhu, Minhao Yan · 2026 · Journal of Radioanalytical and Nuclear Chemistry
  77. Générateur 103Ru/103mRh pour l’Auger-thérapie : de l’étude fondamentale de spéciation des éléments à la preuve de concept
    Marie Théry · 2024
  78. Clinical research analysis of [225Ac]Ac-DOTATATE therapy for neuroendocrine neoplasms
    Hongyu Yang, Meiling Hu, Bingyan Shen, Ya Liu, Lin Liu, Yu Zhang, Yue Chen · 2026 · European Journal of Nuclear Medicine and Molecular Imaging
  79. Effect of dispersive and relativistic optical model potentials on the production cross-section calculation of 225Ac from 232Th using proton energy
    Olumide Oluwasanmi Ige, Tongshinen S. Longmena, Sunday Adesunloye Jonah · 2026 · Nuclear Energy and Technology
  80. PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing
    Natalia Gierulska, Nina Jankowska, Adrianna Kwiatkowska, Piotr Kuchno, Kinga Łysak, Katarzyna Szklener, Kamil Kośmider, Magdalena Skórzewska · 2026 · Oncology Reviews
  81. Monte Carlo Simulation of Medical Isotopes Production by Irradiation of nat U and 232 Th Targets with P, α, 9 Be and 12 C
    Qiuying Liang, Tiancheng Lai, Guanghui Yang, Qiong Yang, Fen Fu, Xunchao Zhang · 2026 · Nuclear Science and Engineering
  82. Avian Eggshell Evolutionary Adaptations Inform Biomimetic Strategies for Next‑Generation Precision Cancer Theranostics
    Zhiqiang Liu, Sida Ling, Mengqi Zhao, Chunyan Zhu, Yaoye Zhou, Hengquan Hou, Hui Zheng, Pengfei Yan, Peng Liu, Chang Yan et al. · 2026 · Advanced Oncology
  83. Targeted Alpha Therapy as a Multiscale Design Problem: From Radioactive Decay to Therapeutic Outcome
    Isidora Lazić, Aljoša Stanković, Nemanja Todorović, Sofija Forkapić, Mladena N. Lalic-Popovic · 2026 · Pharmaceuticals
  84. The value of fibroblast activation protein inhibitor-based radionuclide theranostics in sarcoma: a systematic review
    Yihong Chen, Yaofeng Xiao, Zhe Zhang, Maohua Rao, Zhenyu Yang, Zi Wang, Yu Zhang, Yue Feng, Liang Cai · 2026 · Annals of Nuclear Medicine
  85. Expanding the Theranostic Toolbox: Emerging Therapeutic Isotopes
    Cindy Mariana Ariza Rodríguez, Grace Liles, Suzanne E. Lapi, Jason S. Lewis · 2026 · Journal of Nuclear Medicine
  86. The Second Nitrogen Fits: Development of Diazine-Based Macrocyclic Chelators to Stably Bind Radionuclides Used in Targeted Alpha Therapy
    Magdalena Blei, Lukas Waurick, Björn Drobot, Santiago Andrés Brühlmann, Charlotte Duchemin, Edgars Mamis, Muhammad Inzamam, Thierry Storà, Nadia Audouin, Thomas Sounalet et al. · 2026 · Inorganic Chemistry
  87. Development of Novel 211At-Labeled Agent for Neurotensin Receptor 1-Targeted α-Particle Therapy
    Masayoshi Otsu, Kosuke Saito, Kazuma Nakashima, Hiroyuki Fujimoto, Masashi Murakami, Kazuhiro Ooe, Atsushi Toyoshima, Hiroyuki Watanabe, Masahiro Ono · 2026 · Journal of Medicinal Chemistry
  88. Global clinical trial activity in metastatic castration-resistant prostate cancer from January 2020 to March 2026: a landscape analysis
    Lin Fan, Shuang Wu, Xingxing Xie, Yang Zheng, Longxia Chen, Ruilin Ding · 2026 · Frontiers in Oncology
  89. Evaluation of the In Vivo PET Generator 140 Nd/ 140 Pr Using a HER2-Targeting Agent
    Mangi lal Godara, Volkan Tekin, Hailey A. Houson, Gabriel Dufour, Suzanne E. Lapi · 2026 · Journal of Nuclear Medicine
  90. Revealing the recent potential of 225Ac-radiopharmaceuticals in targeted alpha therapy for solid tumors: mechanisms, clinical trials, and future directions
    Atena Najdian, Malik Eid Juweid, Majid Assadi · 2026 · Nuclear Medicine and Molecular Imaging
  91. Comparative Evaluation of Chelator‐Conjugated Peptides for Lead‐Labeled SSTR2‐Targeted Theranostics: Integrated Computational Modeling and Preclinical Validation
    Jeongyun Kim, Na Han, Ayman Muzammal, Jae Hun Ahn, Changkeun Im, Sujin Kim, Sairan Eom, Choong Mo Kang, Ku Kang, Yong Jin Lee et al. · 2026 · Advanced Science
  92. Targeted radioligand therapy in oncology: clinical development across targets and platforms
    Jiaxin An, Xiaolei Meng, Lara Hathout, Ronald D. Ennis, Xinxin Zhang, Ning Jeff Yue, Matthew Pierre Deek, Salma K. Jabbour · 2026 · Frontiers in Oncology
  93. From β-Blasts to α-Bombs: Bone-Targeting Radiopharmaceutical Therapies
    Nicole E. Chong, Brieanne Wienhoff, Nathan P. Kuo · 2026 · Journal of Nuclear Medicine Technology